**Background**
Gastrointestinal cancers, including colorectal, pancreatic, prostate, and gastric cancers, remain significant global health challenges due to their high morbidity and the complexity of their therapeutic management. Beyond oncology, chronic inflammation and microbial infections often exacerbate tissue damage and contribute to disease progression. Research into naturally occurring compounds has revealed that certain monoterpenes possess multi-functional biological properties, including bactericidal, antifungal, and anti-inflammatory activities. Specifically, compounds derived from aromatic plants have shown promise in suppressing inflammatory mediators and inhibiting the proliferation of malignant cells. In this context, we will introduce a potent monoterpene with diverse therapeutic potential – Terpinen-4-ol.
**Definition**
Terpinen-4-ol (4-Carvomenthenol) is a naturally occurring monoterpene with the Terpinen-4-ol formula C10H18O and a molecular weight of 154.25. It is a potent bactericidal agent that also exhibits significant antifungal, anti-inflammatory, and antitumor properties.
**In Vitro Studies**
According to the Terpinen-4-ol description, this compound can be extracted from various aromatic plants, such as Melaleuca alternifolia (tea tree oil) and Camellia sinensis. Regarding Terpinen-4-ol biological activity, in vitro studies have demonstrated that Terpinen-4-ol (0.005%-0.1% (v/v), 72 h) exerts significant growth inhibition of colorectal, pancreatic, prostate, and gastric cancer cells in a dose-dependent manner. Furthermore, at a concentration of 0.01% (v/v) for 72 h, it enhances the cytotoxicity of combinations with various conventional chemotherapy approaches and biological treatment tools, suggesting its potential as a sensitizer in Terpinen-4-ol Cancer research. In cellular assays, Terpinen-4-ol demonstrated cytotoxicity against human HL-60 cells, with an IC50 value of 30 μM as assessed by MTT assay after 24 hours of treatment. Additionally, it has been shown to suppress the production of inflammatory mediators by activated human monocytes. In conclusion, Terpinen-4-ol is a versatile monoterpene that holds promise as a therapeutic agent for inflammation and human gastrointestinal cancers.
Keywords
Terpinen-4-ol, 562-74-3, 4-Carvomenthenol, Endogenous Metabolite, Bacterial, Fungal, tea-tree, oil, chemotherapeutic, Inhibitor, inhibitor, inhibit
References
[1] Hart PH, et al. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflamm Res. 2000 Nov;49(11):619-26.
[2] Shapira S, et al. Terpinen-4-ol: A Novel and Promising Therapeutic Agent for Human Gastrointestinal Cancers. PLoS One. 2016 Jun 8;11(6):e0156540.